Artificial Intelligence (AI)
American Hospital Association resources on artificial intelligence (AI) and machine learning, their impact on the health care field, and AI and machine learning innovation in hospitals and health systems.
Christine Moutier, M.D., chief medical officer at the American Foundation for Suicide Prevention, discusses the usage of artificial intelligence chatbots among adolescents, the potential dangers for young people experiencing mental health challenges, and the importance of educating clinicians and…
Christine Moutier, M.D., chief medical officer at the American Foundation for Suicide Prevention, discusses the usage of artificial intelligence chatbots among adolescents, the potential dangers for young people experiencing mental health challenges, and the importance of educating clinicians and…
In this conversation, Christine Moutier, M.D., chief medical officer at the American Foundation for Suicide Prevention, discusses the usage of AI chatbots among adolescents,
The AHA Nov. 3 launched a new webpage, Artificial Intelligence Policy and Advocacy, featuring AHA policy letters, statements, fact sheets, news and other resources.
Artificial intelligence helps hospitals improve efficiency, ease documentation burdens, support clinical decisions and enhance patient care.
Six recent collaborations between OpenEvidence and health systems show how providers aim to use the platform to make clinical evidence easier to access, support treatment decisions and extend specialized knowledge.
Mayo Clinic, Johns Hopkins and Johnson & Johnson Nurse Innovation Fellowship recipients illustrate tools for improving workflows, supporting new nurses and strengthening communication with patients and colleagues.
The West Health Accelerator at the AHA’s Health Research & Educational Trust will host a virtual session Oct. 29 at 2:30 p.m. ET on how hospitals are implementing artificial intelligence governance.
The AHA provided recommendations to the Food and Drug Administration Oct. 19 on potential regulatory frameworks for generative artificial intelligence-enabled medical devices.
AHA provides feedback to the Food and Drug Administration on regulatory considerations for generative artificial intelligence (GenAI)-enabled medical devices.